Marine compounds in the treatment of Alzheimer’s disease
This thesis is submitted in partial fulfillment of the requirements for the degree of Bachelor of Pharmacy, 2022.
Päätekijä: | Parveen, Sanjana |
---|---|
Muut tekijät: | Yasmin, Hasina |
Aineistotyyppi: | Opinnäyte |
Kieli: | English |
Julkaistu: |
Brac University
2022
|
Aiheet: | |
Linkit: | http://hdl.handle.net/10361/17302 |
Samankaltaisia teoksia
-
Bio-similar drug development and accessible drugs in the market for the treatment of Alzheimer's Disease: Current status
Tekijä: Tamanna, Mst. Taskia
Julkaistu: (2023) -
Efficacy of Rivastigmine in Alzheimer’s disease- A structured seview
Tekijä: Alim, Abdul
Julkaistu: (2023) -
Role of protein’s and future treatment options for Alzheimer’s Disease
Tekijä: Islam, Md. Irfath
Julkaistu: (2023) -
Exploring the role of programmed cell death protein 1 in alzheimer’s disease associated autoimmunity
Tekijä: Aana, Afsara Sumon
Julkaistu: (2021) -
Knowledge of Alzheimer’s disease and its relationship with attitude towards genetic testing for the disease: a survey of the general public in Bangladesh
Tekijä: Chowdhury, Sariya Uzrat
Julkaistu: (2022)